Skip to main content

. 1983 Jan 29;286(6362):350–351. doi: 10.1136/bmj.286.6362.350-a

Antiemetic effect of nonabine in cancer chemotherapy: a double blind study comparing nonabine and chlorpromazine.

C B Archer, P L Amlot, J R Trounce

PMCID: PMC1546960 PMID: 6402096

350

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Lucas V. S., Jr, Laszlo J. delta 9-Tetrahydrocannabinol for refractory vomiting induced by cancer chemotherapy. JAMA. 1980 Mar 28;243(12):1241–1243. [PubMed] [Google Scholar]
Pars H. G., Howes J. F. Potential therapeutic agents derived from the cannabinoid nucleus. Adv Drug Res. 1977;11:97–189. [PubMed] [Google Scholar]
Sallan S. E., Zinberg N. E., Frei E., 3rd Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy. N Engl J Med. 1975 Oct 16;293(16):795–797. doi: 10.1056/NEJM197510162931603. [DOI] [PubMed] [Google Scholar]
Seigel L. J., Longo D. L. The control of chemotherapy-induced emesis. Ann Intern Med. 1981 Sep;95(3):352–359. doi: 10.7326/0003-4819-95-3-352. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES